The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
EWS/FLI-1 is a chimeric protein formed by a tumor-specific 11;22 translocation found in both Ewing's sarcoma and primitive neuroectodermal tumor of childhood. EWS/FLI-1 has been shown to be a potent transforming gene, suggesting that it plays an important role in the genesis of these human tumors. We now demonstrate that EWS/FLI-1 has the characteristics of an aberrant transcription factor. Subcellular fractionation experiments localized the EWS/FLI-1 protein to the nucleus of primitive neuroectodermal tumor cells. EWS/FLI-1 specifically bound in vitro an ets-2 consensus sequence similarly to normal FLI-1. When coupled to a GAL4 DNA-binding domain, the amino-terminal EWS/FLI-1 region was a much more potent transcriptional activator than the corresponding amino-terminal domain of FLI-1. Finally, EWS/FLI-1 efficiently transformed NIH 3T3 cells, but FLI-1 did not. These data suggest that EWS/FLI-1, functioning as a transcription factor, leads to a phenotype dramatically different from that of cells expressing FLI-1. EWS/FLI-1 could disrupt normal growth and differentiation either by more efficiently activating FLI-1 target genes or by inappropriately modulating genes normally not responsive to FLI-1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The strong transactivation activity in the N terminus of EWS contributes to the function of the resulting oncogenic fusion protein (185).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [185]
Citations
Cites
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
Mitchell, P. J., & Tjian, R. (1989) · Science · doi:10.1126/science.2667136 · Cited by 3,114
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907 · cited 3×
“This polypeptide fragment included EWS amino acid residues 244 to 264 (6) fused to residues 241 to 284 of FLI-1 (30).”
BackgroundMethodde Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma
Crozat, A., Åman, P., Mandahl, N., & Ron, D. (1993) · Nature · doi:10.1038/363640a0 · Cited by 894
The Ets family of transcription factors
WASYLYK, B., HAHN, S. L., & GIOVANE, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb19864.x · Cited by 842
Kamps, M. P., Murre, C., Sun, X.-H., & Baltimore, D. (1990) · Cell · doi:10.1016/0092-8674(90)90658-2 · Cited by 697
Dalton, S., & Treisman, R. (1992) · Cell · doi:10.1016/0092-8674(92)90194-h · Cited by 672
Nourse, J., Mellentin, J. D., Galili, N., Wilkinson, J., Stanbridge, E., Smith, S. D., & Cleary, M. L. (1990) · Cell · doi:10.1016/0092-8674(90)90657-z · Cited by 662
Molecular Analysis of Acute Promyelocytic Leukemia Breakpoint Cluster Region on Chromosome 17
Borrow, J., Goddard, A. D., Sheer, D., & Solomon, E. (1990) · Science · doi:10.1126/science.2218500 · Cited by 632
Stringer, K. F., Ingles, C. J., & Greenblatt, J. (1990) · Nature · doi:10.1038/345783a0 · Cited by 579
Cited by
Items 201–300 of 562
Induction of the interleukin-2/15 receptor β-chain by the EWS–WT1 translocation product
Wong, J. C., Lee, S. B., Bell, M. D., Reynolds, P. A., Fiore, E., Stamenkovic, I., Truong, V. B., Oliner, J. D., Gerald, W. L., & Haber, D. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205262 · Cited by 55
EWS-FLI1 and Ewing’s Sarcoma: Recent Molecular Data and New Insights
Ladanyi, M. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.4.2900 · Cited by 54
Ewing sarcoma from molecular biology to the clinic
Dupuy, M., Lamoureux, F., Mullard, M., Postec, A., Regnier, L., Baud’huin, M., Georges, S., Royer, B. B.-L., Ory, B., Rédiní, F., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1248753 · Cited by 53
Perani, M., Antonson, P., Hamoudi, R., Ingram, C. J. E., Cooper, C. S., Garrett, M. D., & Goodwin, G. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502963200 · Cited by 53
Biology of EWS/FLI and Related Fusion Genesin Ewing’s Sarcoma and Primitive Neuroectodermal Tumor
May, W. A., & Denny, C. T. (1997) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60479-9_9 · Cited by 52
Self-citationLi, K. K. C., & Lee, K. A. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002961200 · Cited by 52
RAS/ERK pathway transcriptional regulation through ETS/AP-1 binding sites
Hollenhorst, P. C. (2012) · Small GTPases · doi:10.4161/sgtp.19630 · Cited by 52
The EWS/NOR1 Fusion Gene Product Gains a Novel Activity Affecting Pre-mRNA Splicing
Ohkura, N., Yaguchi, H., Tsukada, T., & Yamaguchi, K. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109018200 · Cited by 52
HNRNPH1-dependent splicing of a fusion oncogene reveals a targetable RNA G-quadruplex interaction
Neckles, C., Boer, R. E., Aboreden, N. G., Cross, A. M., Walker, R. L., Kim, B., Kim, S. T., Schneekloth, J. S., & Caplen, N. J. (2019) · RNA · doi:10.1261/rna.072454.119 · Cited by 52
Induction of a secreted protein by the myxoid liposarcoma oncogene
Kuroda, M., Wang, X.-Z., Sok, J. C., Yin, Y., Chung, P. W. M., Giannotti, J. W., Jacobs, K. A., Fitz, L. J., Murtha-Riel, P., Turner, K. J., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5025 · Cited by 51
Fujimura, Y., Siddique, H., Lee, L., Rao, V. N., & Reddy, E. S. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204684 · Cited by 50
A Benign Vascular Tumor With a New Fusion Gene: EWSR1-NFATC1 in Hemangioma of the Bone
Arbajian, E., Magnusson, L., Brosjö, O., Wejde, J., Folpe, A. L., Nord, K. H., & Mertens, F. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31827ae13b · Cited by 50
BCL11B Is Up-Regulated by EWS/FLI and Contributes to the Transformed Phenotype in Ewing Sarcoma
Wiles, E. T., Lui, B., Bell, R. N., & Lessnick, S. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059369 · Cited by 49
Self-citationPrognostic significance of p16INK4a alteration for Ewing sarcoma: A meta‐analysis
Honoki, K., Stojanovski, E., McEvoy, M., Fujii, H., Tsujiuchi, T., Kido, A., Takakura, Y., & Attia, J. R. (2007) · Cancer · doi:10.1002/cncr.22908 · Cited by 49
Induction of tenascin‐C by tumor‐specific EWS‐ETS fusion genes
Watanabe, G., Nishimori, H., Irifune, H., Sasaki, Y., Ishida, S., Zembutsu, H., Tanaka, T., Kawaguchi, S., Wada, T., Hata, J., et al. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10153 · Cited by 49
The ETS Family of Transcriptional Regulators
Ghysdael, J., & Boureux, A. (1997) · Oncogenes as Transcriptional Regulators · doi:10.1007/978-3-0348-8889-9_2 · Cited by 48
Sarrazin, S., Starck, J., Gonnet, C., Doubeikovski, A., Mélet, F., & Morlé, F. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.2959-2969.2000 · Cited by 48
Agrá, N., Cidre‐Aranaz, F., García‐García, L., de la Parra, J., & Alonso, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066281 · Cited by 48
Jin, W., Yun, C., Hobbie, A. M., Martin, M. J., Sorensen, P. H. B., & Kim, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3526 · Cited by 48
Special Article: Gene Rearrangements in Ewing's Sarcoma
Denny, C. T. (1996) · Cancer Investigation · doi:10.3109/07357909609018438 · Cited by 48
Self-citationTherapeutic Potentialities of EWS‐Fli‐1 mRNA‐Targeted Vectorized Antisense Oligonucleotides
Maksimenko, A., Lambert, G., Bertrand, J., Fattal, E., Couvreur, P., & Malvy, C. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1281.017 · Cited by 48
Radiological and pathological diagnosis of paediatric bone tumours and tumour-like lesions
Vlychou, M., & Athanasou, N. A. (2008) · Pathology · doi:10.1080/00313020701813784 · Cited by 48
SRE elements are binding sites for the fusion protein EWS-FLI-1
Magnaghi-Jaulin, L. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.6.1052 · Cited by 47
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors
Sandberg, A. A., & Bridge, J. A. (2002) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(02)00680-5 · Cited by 47
Andersson, M. K., Åman, P., & Stenman, G. (2019) · Cells · doi:10.3390/cells8080913 · Cited by 46
Fredericks, W. J., Ayyanathan, K., Herlyn, M., Friedman, J. R., & Rauscher, F. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5019-5031.2000 · Cited by 46
Malignant round cell tumor of bone with EWSR1-NFATC2 gene fusion
Sadri, N., Barroeta, J. E., Pack, S., Abdullaev, Z., Chatterjee, B., Raghunath, P. N., Brooks, J. S., Barr, F. G., & Zhang, P. J. (2014) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-014-1613-7 · Cited by 45
Identification of Target Genes in Their Native Cellular Context
Owen, L. A., & Lessnick, S. L. (2006) · Cell Cycle · doi:10.4161/cc.5.18.3213 · Cited by 45
Self-citationInhibition of Notch Signaling Induces Neural Differentiation in Ewing Sarcoma
Baliko, F., Bright, T., Poon, R. W. M., Cohen, B. L., Egan, S. E., & Alman, B. A. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060971 · Cited by 45
Kang, H., Park, J. H., Chen, W., Kang, S. I., Moroz, K., Ladanyi, M., & Lee, S. B. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3663 · Cited by 45
Llombart‐Bosch, A., Pellín, A., Cardá, C., Noguera, R., Navarro, S., & Peydró-Olaya, A. (2000) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200009000-00003 · Cited by 45
Laflamme, C., Filion, C., Bridge, J. A., Ladanyi, M., Goldring, M. B., & Labelle, Y. (2003) · PubMed · Cited by 45
Inoue, A., Okamoto, K., Fujino, Y., Nakagawa, T., Muguruma, N., Sannomiya, K., Mitsui, Y., Takaoka, T., Kitamura, S., Miyamoto, H., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.545 · Cited by 44
Functional analysis of the EWS/ETS target gene uridine phosphorylase.
Deneen, B., Hamidi, H., & Denny, C. T. (2003) · PubMed · Cited by 43
Self-citationWinter, G. E., Rix, U., Lissat, A., Stukalov, A., Müllner, M. K., Bennett, K. L., Colinge, J., Nijman, S. M. B., Kubicek, S., Kovar, H., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0100 · Cited by 43
Ewing Sarcoma: Biology-Based Therapeutic Perspectives
Potratz, J. C., Jürgens, H., Craft, A. W., & Dirksen, U. (2012) · Pediatric Hematology and Oncology · doi:10.3109/08880018.2011.627582 · Cited by 43
Cui, J.-W., Vecchiarelli-Federico, L. M., Li, Y.-J., Wang, G.-J., & Ben‐David, Y. (2009) · Leukemia · doi:10.1038/leu.2009.20 · Cited by 43
Knezevich, S. R., Hendson, G., Mathers, J. A., Carpenter, B. F., Lopez-Terrada, D. H., Brown, K., & Sorensen, P. H. B. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90049-1 · Cited by 43
Fuchs, B., Inwards, C. Y., & Janknecht, R. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00984-0 · Cited by 42
Nozawa, S., Ohno, T., Banno, Y., Dohjima, T., Wakahara, K., Fan, D.-G., & Shimizu, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411626200 · Cited by 42
FOXM1 Is an Oncogenic Mediator in Ewing Sarcoma
Christensen, L., Joo, J., Lee, S. B., Wai, D., Triche, T. J., & May, W. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054556 · Cited by 42
Self-citationGanjavi, H., Gee, M. F. W., Narendran, A., Freedman, M. H., & Malkin, D. M. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700798 · Cited by 41
TLS-CHOP and the Role of RNA-Binding Proteins in Oncogenic Transformation
Ron, D. (1997) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60479-9_8 · Cited by 41
The emerging role of the myeloid Elf-1 like transcription factorin hematopoiesis
Lacorazza, H. D., & Nimer, S. D. (2003) · Blood Cells Molecules and Diseases · doi:10.1016/s1079-9796(03)00162-1 · Cited by 41
Mangham, D. C., Williams, A., McMullan, D., McClure, J., Sumathi, V. P., Grimer, R. J., & Davies, A. M. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02318.x · Cited by 41
Look, A. T. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60709-5 · Cited by 40
Immunotherapeutic Challenges for Pediatric Cancers
Hutzen, B. J., Ghonime, M. G., Lee, J., Mardis, E. R., Wang, R., Lee, D. A., Cairo, M. S., Roberts, R. D., Cripe, T. P., & Cassady, K. A. (2019) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2019.08.005 · Cited by 39
Phosphorylation of Ewing's sarcoma protein (EWS) and EWS-Fli1 in response to DNA damage
Klevernic, I. V., Morton, S., Davis, R. J., & Cohen, P. (2009) · Biochemical Journal · doi:10.1042/bj20082097 · Cited by 39
Proteasomal Degradation of the EWS-FLI1 Fusion Protein Is Regulated by a Single Lysine Residue
Gierisch, M. E., Pfistner, F., Lopez-Garcia, L. A., Behrmann, L., Schäfer, B. W., & Niggli, F. K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.752063 · Cited by 38
Niedan, S., Kauer, M. O., Aryee, D. N. T., Kofler, R., Schwentner, R., Meier, A., Pötschger, U., Kontny, U., & Kovar, H. (2013) · Oncogene · doi:10.1038/onc.2013.361 · Cited by 38
DeAngelo, D. J., Defalco, J., Rybacki, L., & Childs, G. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1254 · Cited by 38
Szuhai, K., IJszenga, M. J., Tanke, H. J., Rosenberg, C., & Hogendoorn, P. C. W. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.11.006 · Cited by 38
Gascoyne, D. M., Thomas, G., & Latchman, D. S. (2004) · Oncogene · doi:10.1038/sj.onc.1207497 · Cited by 37
Molecular Genetics and Cytogenetics of Sarcomas
Kruzelock, R. P., & Hansen, M. F. (1995) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30082-0 · Cited by 37
Ichikawa, H., Shimizu, K., Katsu, R., & Ohki, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7639 · Cited by 37
FUsed in Sarcoma Is a Novel Regulator of Manganese Superoxide Dismutase Gene Transcription
Dhar, S. K., Zhang, J. Y., Gál, J., Xu, Y., Lu, M., Lynn, B. C., Zhu, H., Kasarskis, E. J., & Clair, D. K. S. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4984 · Cited by 36
Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line
Moore, J. B., Loeb, D. M., Hong, K. U., Sorensen, P. H. B., Triche, T. J., Lee, D. W., Barbato, M. I., & Arceci, R. J. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00015 · Cited by 36
The neonatal Fc receptor in cancer FcRn in cancer
Castaneda, D. C., Brachet, G., Goupille, C., Ouldamer, L., & Gouilleux‐Gruart, V. (2020) · Cancer Medicine · doi:10.1002/cam4.3067 · Cited by 36
Burns, J. S., Abdallah, B. M., Schrøder, H. D., & Kassem, M. S. (2008) · PubMed · doi:10.14670/hh-23.1229 · Cited by 36
Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: A Rare and Lethal Entity
Celli, R., & Cai, G. (2016) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0367-rs · Cited by 36
TGF-beta-dependent and -independent roles of STRAP in cancer
Reiner, J. E., & Datta, P. K. (2010) · Frontiers in bioscience · doi:10.2741/3678 · Cited by 35
Metabolic modulation of Ewing sarcoma cells inhibits tumor growth and stem cell properties
Dasgupta, A., Trucco, M. M., Rainusso, N. C., Bernardi, R. J., Shuck, R. L., Kurenbekova, L., Loeb, D. M., & Yustein, J. T. (2017) · Oncotarget · doi:10.18632/oncotarget.20467 · Cited by 35
Lessnick, S. L., Tos, A. P. D., Sorensen, P. H. B., Dileo, P., Baker, L. H., Ferrari, S., & Hall, K. S. (2009) · Seminars in Oncology · doi:10.1053/j.seminoncol.2009.06.006 · Cited by 35
Self-citationKim, J.-S., Pirnia, F., Choi, Y. H., Nguyen, P. M., Knepper, B., Tsokos, M., Schulte, T. W., Birrer, M. J., Blagosklonny, M. V., Schaefer, O., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1204008 · Cited by 35
Understanding mesenchymal cancer: the liposarcoma-associated FUS–DDIT3 fusion gene as a model
Pérez-Mancera, P. A., & Sánchez-García, I. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.01.006 · Cited by 35
EWS/FLI function varies in different cellular backgrounds
Zwerner, J. P., Guimbellot, J. S., & May, W. A. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00371-9 · Cited by 35
Self-citationReceptor Tyrosine Kinases in Osteosarcoma: Not Just the Usual Suspects
Rettew, A. N., Getty, P. J., & Greenfield, E. M. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_3 · Cited by 34
Theisen, E. R., Selich‐Anderson, J., Miller, K. R., Tanner, J. M., Taslim, C., Pishas, K. I., Sharma, S., & Lessnick, S. L. (2020) · Epigenetics · doi:10.1080/15592294.2020.1805678 · Cited by 34
Self-citationExploiting Replication Stress as a Novel Therapeutic Intervention
Martin, J. C., Hoegel, T. J., Lynch, M. L., Woloszynska‐Read, A., Melendy, T., & Ohm, J. E. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0651 · Cited by 34
Granowetter, L., & West, D. C. (1997) · Cancer treatment and research · doi:10.1007/978-1-4615-5767-8_9 · Cited by 34
γ-Glutamyl transpeptidase expression in Ewing's sarcoma cells:up-regulation by interferons
Bouman, L., Sancéau, J., Rouillard, D., & Bauvois, B. (2002) · Biochemical Journal · doi:10.1042/bj20011854 · Cited by 34
Molecular Genetics in the Diagnosis and Prognosis of Solid Pediatric Tumors
Thorner, P. S., & Squire, J. A. (1998) · Pediatric and Developmental Pathology · doi:10.1007/s100249900049 · Cited by 33
EWS/FLI1 suppresses retinoblastoma protein function and senescence in Ewing's sarcoma cells
Hu, H., Zielinska‐Kwiatkowska, A., Munro, K., Wilcox, J. J., Wu, D. Y., Yang, L., & Chansky, H. A. (2008) · Journal of Orthopaedic Research® · doi:10.1002/jor.20597 · Cited by 33
New diagnostic modalities in soft tissue sarcoma
Singer, S. (1999) · Seminars in Surgical Oncology · doi:10.1002/(sici)1098-2388(199907/08)17:1<11::aid-ssu3>3.0.co;2-0 · Cited by 33
Szuhai, K., IJszenga, M. J., Tanke, H. J., Taminiau, A. H. M., de Schepper, A., van Duinen, S. G., Rosenberg, C., & Hogendoorn, P. C. W. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2006.07.007 · Cited by 31
FET family proto-oncogene Fus contributes to self-renewal of hematopoietic stem cells
Sugawara, T., Oguro, H., Negishi, M., Morita, Y., Ichikawa, H., Iseki, T., Yokosuka, O., Nakauchi, H., & Iwama, A. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.04.006 · Cited by 31
Feng, L., & Lee, K. A. W. (2001) · Oncogene · doi:10.1038/sj.onc.1204522 · Cited by 30
Peripheral primitive neuroectodermal tumor of the stomach in a 14-year-old boy: a case report
Czekalla, R., Fuchs, M., lzle, A. S., Nerlich, M. L., Poremba, C., Schaefer, K., Weirich, G., H??fler, H., Schneller, F., Peschel, C., et al. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200412000-00026 · Cited by 30
Melot, T., Gruel, N., Doubeikovski, A., Sévenet, N., Teillaud, J., & Delattre, O. (1997) · Hybridoma · doi:10.1089/hyb.1997.16.457 · Cited by 30
Kleinbaum, L. A., Duggan, C. R., Ferreira, E., Coffey, G., Butticè, G., & Burton, F. H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1493 · Cited by 29
AnEWS/ERG fusion with a truncated N-terminal domain ofEWS in a Ewing's tumor
Peter, M., Mugneret, F., Aurias, A., Thomas, G. D., Magdelénat, H., & Delattre, O. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960729)67:3<339::aid-ijc6>3.0.co;2-s · Cited by 29
Song, W., Li, W., Li, L., Zhang, S., Xu, Y., Wen, X., Zhang, X., Tian, H., Li, A., Hu, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4350 · Cited by 29
Population-based genetic alterations in Ewing’s tumors from Japanese and European Caucasian patients
Ozaki, T., Schaefer, K., Wai, D., Yokoyama, R., Ahrens, S., Diallo, R. I., Hasegawa, T., Shimoda, T., Hirohashi, S., Kawai, A., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf218 · Cited by 29
Peripheral primitive neuroectodermal tumors in adults: documentation by molecular analysis.
Lawlor, E. R., Mathers, J. A., Bainbridge, T., Horsman, D. E., Kawai, A., Healey, J. H., Huvos, A. G., Bridge, J. A., Ladanyi, M., & Sorensen, P. H. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1150 · Cited by 29
Transformation of Ba/F3 cells and Rat-1 cells by ETV6/ARG
Iijima, Y., Okuda, K., Tojo, A., Tri, N. K., Setoyama, M., Sakaki, Y., Asano, S., Tokunaga, K., Kruh, G. D., & Sato, Y. (2002) · Oncogene · doi:10.1038/sj.onc.1205544 · Cited by 29
Li, X., Tanaka, K., Nakatani, F., Matsunobu, T., Sakimura, R., Hanada, M., Okada, T., Nakamura, T., & Iwamoto, Y. (2005) · International Journal of Cancer · doi:10.1002/ijc.21010 · Cited by 28
Ewingʼs Sarcoma—A Clinical Enigma Coming Into Focus
Denny, C. T. (1998) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199809000-00002 · Cited by 28
Self-citationFrance, K. A., Anderson, J. L., Park, A., & Denny, C. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.225433 · Cited by 28
Self-citationThe cytogenetic and molecular characterization of benign and malignant soft tissue tumors
Sreekantaiah, C. (1998) · Cytogenetic and Genome Research · doi:10.1159/000015056 · Cited by 27
Notch signaling in pediatric soft tissue sarcomas
Rota, R., Ciarapica, R., Miele, L., & Locatelli, F. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-141 · Cited by 27
Functions of Heterogeneous Nuclear Ribonucleoproteins in Stem Cell Potency and Differentiation
Chen, Q., Jin, M., Zhu, J., Xiao, Q., & Zhang, L. (2013) · BioMed Research International · doi:10.1155/2013/623978 · Cited by 27
Theisen, E. R., Miller, K. R., Showpnil, I. A., Taslim, C., Pishas, K. I., & Lessnick, S. L. (2019) · Genes & Cancer · doi:10.18632/genesandcancer.188 · Cited by 27
Self-citationPhase separation of the oncogenic fusion protein EWS::FLI1 is modulated by its DNA-binding domain
Selig, E. E., Sohn, E. J., Stoja, A. P., Moreno-Romero, A. K., Akula, S., Xu, X., Bishop, A. J. R., & Libich, D. S. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2221823122 · Cited by 26
Factors Affecting EWS-FLI1 Activity in Ewing's Sarcoma
Herrero‐Martín, D., Fourtouna, A., Niedan, S., Riedmann, L. T., Schwentner, R., & Aryee, D. N. T. (2011) · Sarcoma · doi:10.1155/2011/352580 · Cited by 26
Matushansky, I., & Maki, R. G. (2005) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2005.03.006 · Cited by 26
Enguita‐Germán, M., Schiapparelli, P. V., REY, J. A., & Castresana, J. S. (2010) · Tumor Biology · doi:10.1007/s13277-010-0046-4 · Cited by 26
RUNX3 Facilitates Growth of Ewing Sarcoma Cells
Bledsoe, K. L., McGee‐Lawrence, M. E., Camilleri, E. T., Wang, X., Riester, S. M., van Wijnen, A. J., Oliveira, A. M., & Westendorf, J. J. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24663 · Cited by 25
Manipulation of oxidative stress to induce cell death in Ewing’s sarcoma family of tumours
Magwere, T., Myatt, S. S., & Burchill, S. A. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.06.008 · Cited by 25
Anticancer Use of Nanoparticles as Nucleic Acid Carriers
Gözüaçık, D., Acar, H. F. Y., Akkoç, Y., Koşar, A., Ekici, I. D., & Ekici, S. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1935 · Cited by 25
Breakthrough Technologies Reshape the Ewing Sarcoma Molecular Landscape
Salguero‐Aranda, C., Amaral, A. T., Olmedo-Pelayo, J., Díaz‐Martín, J., & de Álava, E. (2020) · Cells · doi:10.3390/cells9040804 · Cited by 25
Metadata
- Authors
- May, W. A., Lessnick, S. L., Braun, B. S., Klemsz, M., Lewis, B. C., Lunsford, L. B., Hromas, R., & Denny, C. T.
- Affiliations
- University of California, Los Angeles (US)
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1993-12
- Volume
- 13
- Issue
- 12
- Pages
- 7393-7398
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC364810
- OpenAlex
- W1789215739
- Cited by
- 497
- References
- 33
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 13 · 2022: 8 · 2021: 12 · 2020: 14 · 2019: 14 · 2018: 10 · 2017: 8 · 2016: 16 · 2015: 15 · 2014: 22 · 2013: 25 · 2012: 20
- FWCI
- 11.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute
- National Institute of General Medical Sciences (T32GM008042)
- National Institute of Allergy and Infectious Diseases (T32AI007126)
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- FLI1, Ewing sarcoma, primitive neuroectodermal tumor, 22 translocation, transcriptional activator, GAL4 DNA-binding domain, nuclear localization
- MeSH terms
- Animals, Base Sequence, Binding Sites, Cell Line, Cell Nucleus, Cell Transformation, Neoplastic, Chromosomes, Human, Pair 11, Chromosomes, Human, Pair 22, Cloning, Molecular, DNA-Binding Proteins, DNA, Neoplasm, HeLa Cells, Humans, Molecular Sequence Data, Oncogenes, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Sarcoma, Ewing, Translocation, Genetic, Trans-Activators, 3T3 Cells, Mice, Proto-Oncogene Protein c-fli-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.